Zombie NIR™ Fixable Viability Kit Zombie NIR™ Fixable Viability Kit

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixable Dye, Fixable Viability Dye, Dead, Apoptosis
Ave. Rating
Submit a Review
Product Citations
publications
Zombie_NIR_Antibody_FC_062413
One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
  • Zombie_NIR_Antibody_FC_062413
    One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
See Zombie NIR™ spectral data
Cat # Size Price Quantity Check Availability Save
423105 100 tests DKK529
Check Availability


Need larger quantities of this item?
Request Bulk Quote
423106 500 tests DKK1990
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Zombie NIR™ is an amine reactive fluorescent dye that is non-permeant to live cells, but permeant to the cells with compromised membranes. Thus, it can be used to assess live vs. dead status of mammalian cells. Zombie NIR™ is a polar water soluble dye, providing red fluorescence, making it suitable for multi-color detection.

Product Details
Technical Data Sheet (pdf)

Product Details

Preparation
Zombie NIR™ Fixable Viability kit is composed of lyophilized Zombie NIR™ dye and anhydrous DMSO. For reconstitution, bring the kit to room temperature; add 100 µl of DMSO to one vial of Zombie NIR™ dye until fully dissolved. 100 tests = 1 vial of Zombie NIR™ + DMSO, 500 tests = 5 vials of Zombie NIR™ + DMSO.
Storage & Handling
Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie NIR™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.
Application

FC - Quality tested

Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis.

For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type.

Excitation Laser
Red Laser (633 nm)
Application Notes

Zombie NIR™ dye is excited by the red laser and has fluorescence emission maximum at 746 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie NIR™ dye has similar emission to APC/Cyanine7.

Standard Cell Staining Protocol:

  1. Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrofuge to ensure the reagent is at the bottom of the vial.
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully dissolved
  3. Wash cells with PBS buffer (no Tris buffer and protein free).
  4. Dilute Zombie NIR™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µL Zombie NIR™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µL for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  5. Incubate the cells at room temperature (or 4°C), in the dark, for 15-30 minutes.
  6. Wash one time with 2 mL BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA.
  7. Continue performing antibody staining procedure as desired.
  8. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation.

No-wash Sequential Staining Protocol:

  1. Wash cells with PBS buffer (no Tris buffer and protein free).
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully  dissolved
  3. Determine the total µL volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µL. Subtract that antibody volume from the 100 µL total staining volume intended for the assay. In the remaining volume, dilute Zombie NIR™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µL of antibody cocktail for a 100 µL total staining volume, use 80 µL of Zombie NIR™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie NIR™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  4. Incubate for 10-15 minutes at RT (or 4°C), protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes.
  5. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet.
  6. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells.
    • Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie NIR™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie NIR™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie NIR™.
Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. McMaster SR, et al. 2015. PLoS One. 10:115725. PubMed
  2. Prado-Garcia H, et al. 2015. Anticancer Res.35:1529. PubMed
  3. Rodriguez-Rodriguez N, et al. 2015. J Immunol. 194:4207. PubMed
  4. Flies DB, et al. 2015. J Immunol. 194:5294. PubMed
Product Citations
  1. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  2. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  3. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  4. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  5. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  6. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  7. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  8. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  9. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  10. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  11. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  12. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  13. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  14. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  15. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  16. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  17. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  18. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  19. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  20. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  21. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  22. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  23. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  24. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  25. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  26. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  27. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  28. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  29. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  30. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  31. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  32. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  33. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  34. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  35. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  36. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  37. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  38. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  39. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  40. Pleuger C, et al. 2022. Elife. 11: . PubMed
  41. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  42. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  43. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  44. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  45. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  46. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  47. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  48. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  49. Rosain J, et al. 2023. Cell. 186:621. PubMed
  50. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  51. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  52. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  53. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  54. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  55. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  56. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  57. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  58. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  59. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  60. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  61. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  62. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  63. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  64. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  65. Zhao Y, et al. 2022. J Neurosci. . PubMed
  66. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  67. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  68. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  69. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  70. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  71. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  72. Han X, et al. 2022. Nutrients. 14:. PubMed
  73. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  74. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  75. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  76. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  77. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  78. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  79. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  80. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  81. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  82. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  83. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  84. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  85. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  86. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  87. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  88. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  89. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  90. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  91. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  92. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  93. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  94. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  95. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  96. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  97. Imai H, et al. 2023. iScience. 26:106822. PubMed
  98. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  99. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  100. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  101. Wu L, et al. 2023. Cell Res. . PubMed
  102. Cansever D, et al. 2023. Nat Immunol. . PubMed
  103. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  104. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  105. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  106. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  107. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  108. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  109. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  110. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  111. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  112. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  113. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  114. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  115. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  116. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  117. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  118. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  119. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  120. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  121. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  122. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  123. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  124. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  125. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  126. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  127. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  128. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  129. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  130. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  131. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  132. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  133. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  134. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  135. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  136. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  137. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  138. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  139. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  140. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  141. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  142. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  143. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  144. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  145. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  146. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  147. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  148. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  149. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  150. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  151. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  152. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  153. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  154. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  155. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  156. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  157. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  158. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  159. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  160. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  161. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  162. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  163. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  164. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  165. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  166. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  167. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  168. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  169. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  170. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  171. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  172. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  173. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  174. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  175. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  176. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  177. Woodruff MC, et al. 2022. Nature. :. PubMed
  178. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  179. Akiyama H, et al. 2020. J Virol. . PubMed
  180. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  181. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  182. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  183. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  184. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  185. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  186. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  187. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  188. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  189. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  190. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  191. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  192. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  193. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  194. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  195. Mills C, et al. 2022. Cells. 11:. PubMed
  196. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  197. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  198. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  199. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  200. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  201. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  202. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  203. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  204. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  205. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  206. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  207. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  208. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  209. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  210. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  211. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  212. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  213. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  214. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  215. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  216. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  217. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  218. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  219. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  220. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  221. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  222. Wang Z, et al. 2021. bioRxiv. . PubMed
  223. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  224. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  225. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  226. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  227. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  228. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  229. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  230. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  231. Woodruff M, et al. 2020. medRxiv. . PubMed
  232. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  233. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  234. English KG, et al. 2022. Biomedicines. 10:. PubMed
  235. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  236. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  237. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  238. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  239. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  240. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  241. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  242. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  243. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  244. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  245. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  246. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  247. Popay TM, et al. 2021. Elife. 10: . PubMed
  248. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  249. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  250. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  251. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  252. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  253. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  254. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  255. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  256. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  257. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  258. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  259. Ito Y, et al. 2018. Cell. 174:636. PubMed
  260. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  261. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  262. Elias G, et al. 2022. Elife. 11:. PubMed
  263. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  264. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  265. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  266. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  267. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  268. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  269. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  270. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  271. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  272. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  273. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  274. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  275. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  276. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  277. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  278. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  279. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  280. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  281. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  282. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  283. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  284. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  285. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  286. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  287. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  288. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  289. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  290. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  291. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  292. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  293. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  294. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  295. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  296. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  297. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  298. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  299. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  300. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  301. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  302. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  303. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  304. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  305. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  306. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  307. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  308. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  309. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  310. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  311. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  312. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  313. Wang Z, et al. 2021. Nature. 592:616. PubMed
  314. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  315. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  316. Dudek M, et al. 2021. Nature. 592:444. PubMed
  317. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  318. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  319. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  320. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  321. He Y, et al. 2022. Cells. 11:. PubMed
  322. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  323. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  324. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  325. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  326. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  327. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  328. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  329. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  330. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  331. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  332. Wang Z, et al. 2021. Nature. 595:426. PubMed
  333. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  334. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  335. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  336. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  337. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  338. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  339. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  340. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  341. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  342. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  343. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  344. Korin B, et al. 2020. Sleep. :43. PubMed
  345. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  346. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  347. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  348. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  349. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  350. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  351. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  352. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  353. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  354. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  355. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  356. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  357. Gaebler C, et al. 2020. bioRxiv. . PubMed
  358. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  359. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  360. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  361. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  362. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  363. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  364. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  365. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  366. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  367. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  368. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  369. Viant C, et al. 2020. Cell. 183:1298. PubMed
  370. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  371. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  372. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  373. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  374. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  375. Sibler E, et al. 2021. Cells. 10:. PubMed
  376. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  377. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  378. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  379. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  380. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  381. Spath S, et al. 2022. iScience. 25:104998. PubMed
  382. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  383. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  384. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  385. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  386. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  387. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  388. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  389. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  390. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  391. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  392. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  393. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  394. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  395. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  396. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  397. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  398. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  399. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  400. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed
  401. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  402. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  403. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  404. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  405. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  406. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  407. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  408. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  409. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  410. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  411. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  412. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  413. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  414. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  415. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  416. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  417. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  418. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  419. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  420. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  421. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  422. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  423. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  424. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  425. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  426. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  427. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  428. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  429. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  430. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  431. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  432. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  433. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  434. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  435. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  436. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  437. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  438. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  439. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  440. Pleuger C, et al. 2022. Elife. 11: . PubMed
  441. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  442. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  443. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  444. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  445. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  446. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  447. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  448. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  449. Rosain J, et al. 2023. Cell. 186:621. PubMed
  450. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  451. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  452. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  453. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  454. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  455. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  456. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  457. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  458. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  459. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  460. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  461. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  462. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  463. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  464. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  465. Zhao Y, et al. 2022. J Neurosci. . PubMed
  466. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  467. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  468. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  469. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  470. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  471. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  472. Han X, et al. 2022. Nutrients. 14:. PubMed
  473. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  474. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  475. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  476. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  477. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  478. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  479. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  480. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  481. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  482. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  483. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  484. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  485. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  486. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  487. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  488. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  489. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  490. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  491. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  492. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  493. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  494. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  495. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  496. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  497. Imai H, et al. 2023. iScience. 26:106822. PubMed
  498. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  499. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  500. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  501. Wu L, et al. 2023. Cell Res. . PubMed
  502. Cansever D, et al. 2023. Nat Immunol. . PubMed
  503. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  504. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  505. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  506. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  507. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  508. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  509. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  510. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  511. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  512. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  513. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  514. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  515. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  516. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  517. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  518. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  519. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  520. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  521. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  522. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  523. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  524. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  525. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  526. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  527. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  528. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  529. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  530. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  531. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  532. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  533. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  534. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  535. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  536. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  537. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  538. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  539. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  540. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  541. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  542. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  543. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  544. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  545. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  546. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  547. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  548. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  549. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  550. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  551. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  552. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  553. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  554. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  555. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  556. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  557. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  558. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  559. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  560. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  561. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  562. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  563. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  564. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  565. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  566. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  567. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  568. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  569. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  570. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  571. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  572. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  573. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  574. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  575. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  576. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  577. Woodruff MC, et al. 2022. Nature. :. PubMed
  578. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  579. Akiyama H, et al. 2020. J Virol. . PubMed
  580. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  581. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  582. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  583. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  584. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  585. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  586. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  587. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  588. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  589. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  590. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  591. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  592. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  593. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  594. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  595. Mills C, et al. 2022. Cells. 11:. PubMed
  596. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  597. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  598. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  599. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  600. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  601. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  602. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  603. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  604. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  605. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  606. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  607. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  608. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  609. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  610. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  611. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  612. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  613. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  614. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  615. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  616. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  617. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  618. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  619. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  620. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  621. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  622. Wang Z, et al. 2021. bioRxiv. . PubMed
  623. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  624. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  625. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  626. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  627. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  628. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  629. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  630. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  631. Woodruff M, et al. 2020. medRxiv. . PubMed
  632. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  633. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  634. English KG, et al. 2022. Biomedicines. 10:. PubMed
  635. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  636. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  637. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  638. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  639. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  640. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  641. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  642. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  643. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  644. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  645. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  646. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  647. Popay TM, et al. 2021. Elife. 10: . PubMed
  648. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  649. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  650. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  651. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  652. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  653. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  654. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  655. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  656. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  657. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  658. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  659. Ito Y, et al. 2018. Cell. 174:636. PubMed
  660. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  661. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  662. Elias G, et al. 2022. Elife. 11:. PubMed
  663. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  664. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  665. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  666. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  667. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  668. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  669. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  670. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  671. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  672. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  673. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  674. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  675. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  676. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  677. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  678. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  679. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  680. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  681. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  682. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  683. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  684. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  685. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  686. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  687. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  688. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  689. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  690. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  691. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  692. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  693. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  694. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  695. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  696. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  697. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  698. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  699. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  700. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  701. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  702. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  703. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  704. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  705. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  706. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  707. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  708. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  709. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  710. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  711. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  712. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  713. Wang Z, et al. 2021. Nature. 592:616. PubMed
  714. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  715. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  716. Dudek M, et al. 2021. Nature. 592:444. PubMed
  717. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  718. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  719. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  720. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  721. He Y, et al. 2022. Cells. 11:. PubMed
  722. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  723. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  724. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  725. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  726. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  727. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  728. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  729. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  730. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  731. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  732. Wang Z, et al. 2021. Nature. 595:426. PubMed
  733. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  734. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  735. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  736. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  737. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  738. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  739. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  740. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  741. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  742. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  743. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  744. Korin B, et al. 2020. Sleep. :43. PubMed
  745. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  746. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  747. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  748. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  749. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  750. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  751. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  752. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  753. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  754. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  755. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  756. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  757. Gaebler C, et al. 2020. bioRxiv. . PubMed
  758. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  759. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  760. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  761. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  762. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  763. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  764. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  765. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  766. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  767. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  768. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  769. Viant C, et al. 2020. Cell. 183:1298. PubMed
  770. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  771. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  772. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  773. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  774. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  775. Sibler E, et al. 2021. Cells. 10:. PubMed
  776. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  777. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  778. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  779. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  780. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  781. Spath S, et al. 2022. iScience. 25:104998. PubMed
  782. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  783. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  784. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  785. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  786. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  787. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  788. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  789. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  790. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  791. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  792. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  793. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  794. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  795. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  796. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  797. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  798. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  799. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  800. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
NA

Related FAQs

I am concerned about the spillover I am observing from the Zombie dye into its neighboring channels.
Rule of thumb with Zombie dyes is to titrate them down as much as possible to fit your application. This should potentially help with spillover. Secondly, Zombie positive events represent dead cells and are typically gated out from analysis.
How does the performance of your Zombie dye compare with competitors?

Zombie dyes have been tested against other leading competitors' fixable viability kits and given comparable results. We also highly recommend that you titrate down the amount of each dye used in order to best match the negative signals of your unstained sample and MFI- (mean fluorescence intensity) stained samples.

Can I use methanol/ethanol for fixation after using a Zombie dye?

Yes, most fixation reagents are fine to be used with Zombie dyes. However, it should be noted that Zombie dyes can still be sensitive to reactive oxygen species. Light exposure or reagents with hydrogen peroxide can lead to free radical formation, affecting fluorescence.

Can Zombie be used to determine bacteria, yeast viability?
We have not tested in house bacterial or yeast viability using Zombie dyes. It is not clear whether the difference between surface and intracellular signals will be significantly different in case of non mammalian cells.
Can I use Zombie with cells suspension containing serum?
Serum is full of proteins which will sequester the dye and thereby reducing its effective concentration. The basic rule of thumb with zombie is to titrate it based on your specific condition. Titration also helps reduce the background and spillover into other channels.
Can I use Zombie dyes for microscopy?

Zombie dyes tested in-house for microscopy applications will display data on the product technical datasheet. It should be noted that Zombie dyes may not work for dead cell discrimination in every microscopy application. Important considerations that may impact analysis are determining the signal level that constitutes a dead cell and identifying the proper plane to observe the dead cells.

Why can't I fix my cells prior to using Zombie dyes?

The fixation process can contort and alter the membrane of cells, effectively rendering them dead. Since the ability of the Zombie dyes to stain dead cells is correlated with cell permeability, your results may no longer be a valid representation of dead versus live cells.

Can I use Zombie dyes to detect apoptotic cells?

Yes, Zombie dyes can be used with apoptosis markers, such as Annexin V or Apotracker™ (shown below), to discriminate live, apoptotic, and dead cells.

One day-old C57BL/6 mouse thymocytes were stained with Apotracker™ Tetra Alexa Fluor® 647 and Zombie™ YG581. Zombie-dim/Apotracker™-positive cells are apoptotic, while double-positive cells are dead. Live cells are negative for both markers.

How should I store Zombie dyes?

Store the Zombie dye kit at -20°C upon receipt. Do not open vials until needed. Once DMSO is added, use immediately or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.

Go To Top Version: 7    Revision Date: 12/18/2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixable Dye, Fixable Viability Dye, Dead, Apoptosis
Ave. Rating
Submit a Review
Product Citations
publications
Zombie_NIR_Antibody_FC_062413
One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
  • Zombie_NIR_Antibody_FC_062413
    One day old C57BL/6 mouse splenocytes were stained with Zombie NIR™ and analyzed before fixation (purple) or after fixation and permeabilization (red). Cells alone, without Zombie NIR™ staining, are indicated in black.
See Zombie NIR™ spectral data
Cat # Size Price Quantity Check Availability Save
423105 100 tests DKK529
Check Availability


Need larger quantities of this item?
Request Bulk Quote
423106 500 tests DKK1990
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Zombie NIR™ is an amine reactive fluorescent dye that is non-permeant to live cells, but permeant to the cells with compromised membranes. Thus, it can be used to assess live vs. dead status of mammalian cells. Zombie NIR™ is a polar water soluble dye, providing red fluorescence, making it suitable for multi-color detection.

Product Details
Technical Data Sheet (pdf)

Product Details

Preparation
Zombie NIR™ Fixable Viability kit is composed of lyophilized Zombie NIR™ dye and anhydrous DMSO. For reconstitution, bring the kit to room temperature; add 100 µl of DMSO to one vial of Zombie NIR™ dye until fully dissolved. 100 tests = 1 vial of Zombie NIR™ + DMSO, 500 tests = 5 vials of Zombie NIR™ + DMSO.
Storage & Handling
Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie NIR™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.
Application

FC - Quality tested

Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis.

For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type.

Excitation Laser
Red Laser (633 nm)
Application Notes

Zombie NIR™ dye is excited by the red laser and has fluorescence emission maximum at 746 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie NIR™ dye has similar emission to APC/Cyanine7.

Standard Cell Staining Protocol:

  1. Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrofuge to ensure the reagent is at the bottom of the vial.
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully dissolved
  3. Wash cells with PBS buffer (no Tris buffer and protein free).
  4. Dilute Zombie NIR™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µL Zombie NIR™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µL for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  5. Incubate the cells at room temperature (or 4°C), in the dark, for 15-30 minutes.
  6. Wash one time with 2 mL BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA.
  7. Continue performing antibody staining procedure as desired.
  8. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation.

No-wash Sequential Staining Protocol:

  1. Wash cells with PBS buffer (no Tris buffer and protein free).
  2. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie NIR™ dye and mix until fully  dissolved
  3. Determine the total µL volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µL. Subtract that antibody volume from the 100 µL total staining volume intended for the assay. In the remaining volume, dilute Zombie NIR™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µL of antibody cocktail for a 100 µL total staining volume, use 80 µL of Zombie NIR™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie NIR™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death.
    • Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS.
    • Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells.
  4. Incubate for 10-15 minutes at RT (or 4°C), protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes.
  5. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet.
  6. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells.
    • Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie NIR™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie NIR™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie NIR™.
Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. McMaster SR, et al. 2015. PLoS One. 10:115725. PubMed
  2. Prado-Garcia H, et al. 2015. Anticancer Res.35:1529. PubMed
  3. Rodriguez-Rodriguez N, et al. 2015. J Immunol. 194:4207. PubMed
  4. Flies DB, et al. 2015. J Immunol. 194:5294. PubMed
Product Citations
  1. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  2. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  3. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  4. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  5. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  6. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  7. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  8. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  9. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  10. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  11. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  12. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  13. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  14. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  15. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  16. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  17. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  18. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  19. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  20. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  21. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  22. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  23. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  24. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  25. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  26. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  27. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  28. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  29. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  30. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  31. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  32. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  33. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  34. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  35. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  36. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  37. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  38. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  39. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  40. Pleuger C, et al. 2022. Elife. 11: . PubMed
  41. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  42. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  43. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  44. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  45. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  46. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  47. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  48. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  49. Rosain J, et al. 2023. Cell. 186:621. PubMed
  50. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  51. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  52. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  53. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  54. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  55. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  56. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  57. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  58. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  59. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  60. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  61. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  62. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  63. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  64. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  65. Zhao Y, et al. 2022. J Neurosci. . PubMed
  66. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  67. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  68. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  69. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  70. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  71. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  72. Han X, et al. 2022. Nutrients. 14:. PubMed
  73. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  74. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  75. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  76. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  77. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  78. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  79. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  80. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  81. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  82. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  83. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  84. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  85. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  86. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  87. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  88. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  89. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  90. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  91. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  92. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  93. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  94. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  95. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  96. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  97. Imai H, et al. 2023. iScience. 26:106822. PubMed
  98. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  99. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  100. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  101. Wu L, et al. 2023. Cell Res. . PubMed
  102. Cansever D, et al. 2023. Nat Immunol. . PubMed
  103. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  104. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  105. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  106. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  107. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  108. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  109. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  110. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  111. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  112. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  113. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  114. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  115. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  116. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  117. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  118. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  119. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  120. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  121. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  122. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  123. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  124. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  125. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  126. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  127. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  128. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  129. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  130. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  131. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  132. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  133. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  134. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  135. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  136. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  137. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  138. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  139. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  140. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  141. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  142. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  143. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  144. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  145. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  146. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  147. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  148. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  149. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  150. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  151. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  152. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  153. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  154. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  155. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  156. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  157. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  158. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  159. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  160. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  161. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  162. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  163. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  164. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  165. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  166. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  167. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  168. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  169. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  170. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  171. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  172. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  173. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  174. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  175. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  176. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  177. Woodruff MC, et al. 2022. Nature. :. PubMed
  178. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  179. Akiyama H, et al. 2020. J Virol. . PubMed
  180. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  181. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  182. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  183. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  184. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  185. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  186. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  187. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  188. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  189. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  190. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  191. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  192. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  193. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  194. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  195. Mills C, et al. 2022. Cells. 11:. PubMed
  196. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  197. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  198. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  199. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  200. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  201. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  202. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  203. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  204. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  205. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  206. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  207. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  208. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  209. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  210. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  211. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  212. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  213. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  214. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  215. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  216. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  217. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  218. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  219. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  220. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  221. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  222. Wang Z, et al. 2021. bioRxiv. . PubMed
  223. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  224. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  225. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  226. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  227. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  228. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  229. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  230. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  231. Woodruff M, et al. 2020. medRxiv. . PubMed
  232. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  233. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  234. English KG, et al. 2022. Biomedicines. 10:. PubMed
  235. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  236. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  237. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  238. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  239. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  240. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  241. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  242. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  243. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  244. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  245. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  246. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  247. Popay TM, et al. 2021. Elife. 10: . PubMed
  248. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  249. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  250. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  251. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  252. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  253. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  254. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  255. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  256. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  257. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  258. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  259. Ito Y, et al. 2018. Cell. 174:636. PubMed
  260. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  261. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  262. Elias G, et al. 2022. Elife. 11:. PubMed
  263. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  264. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  265. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  266. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  267. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  268. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  269. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  270. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  271. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  272. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  273. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  274. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  275. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  276. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  277. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  278. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  279. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  280. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  281. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  282. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  283. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  284. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  285. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  286. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  287. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  288. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  289. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  290. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  291. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  292. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  293. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  294. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  295. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  296. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  297. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  298. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  299. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  300. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  301. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  302. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  303. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  304. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  305. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  306. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  307. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  308. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  309. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  310. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  311. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  312. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  313. Wang Z, et al. 2021. Nature. 592:616. PubMed
  314. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  315. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  316. Dudek M, et al. 2021. Nature. 592:444. PubMed
  317. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  318. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  319. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  320. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  321. He Y, et al. 2022. Cells. 11:. PubMed
  322. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  323. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  324. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  325. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  326. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  327. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  328. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  329. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  330. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  331. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  332. Wang Z, et al. 2021. Nature. 595:426. PubMed
  333. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  334. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  335. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  336. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  337. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  338. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  339. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  340. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  341. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  342. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  343. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  344. Korin B, et al. 2020. Sleep. :43. PubMed
  345. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  346. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  347. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  348. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  349. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  350. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  351. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  352. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  353. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  354. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  355. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  356. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  357. Gaebler C, et al. 2020. bioRxiv. . PubMed
  358. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  359. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  360. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  361. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  362. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  363. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  364. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  365. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  366. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  367. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  368. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  369. Viant C, et al. 2020. Cell. 183:1298. PubMed
  370. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  371. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  372. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  373. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  374. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  375. Sibler E, et al. 2021. Cells. 10:. PubMed
  376. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  377. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  378. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  379. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  380. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  381. Spath S, et al. 2022. iScience. 25:104998. PubMed
  382. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  383. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  384. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  385. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  386. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  387. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  388. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  389. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  390. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  391. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  392. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  393. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  394. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  395. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  396. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  397. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  398. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  399. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  400. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed
  401. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  402. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
  403. Headley M, et al. 2016. Nature. 531:513-517. PubMed
  404. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  405. Iyer S, et al. 2021. Cancer Discov. 0.725. PubMed
  406. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  407. Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed
  408. Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
  409. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  410. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  411. Wu R, et al. 2022. J Dermatol. 49:432. PubMed
  412. Wang W, et al. 2022. Dev Cell. 57:228. PubMed
  413. Chaurio RA, et al. 2022. Immunity. 55:115. PubMed
  414. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  415. Kuloglu ZE, et al. 2022. Allergy. 77:2459. PubMed
  416. Bayley R, et al. 2022. Mol Cell. 82:1924. PubMed
  417. Rodriguez-Tirado C, et al. 2022. Cancer Res. 82:2313. PubMed
  418. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  419. Gideon HP, et al. 2022. Immunity. 55:827. PubMed
  420. Zhang Y, et al. 2022. Nat Med. 28:1421. PubMed
  421. Sudmeier LJ, et al. 2022. Cell Rep Med. 3:100620. PubMed
  422. Naseem MU, et al. 2022. J Gen Physiol. 154: . PubMed
  423. Vukovic N, et al. 2022. J Biol Chem. 298:102153. PubMed
  424. Berger G, et al. 2022. Proc Natl Acad Sci U S A. 119:e2111003119. PubMed
  425. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  426. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  427. Zhu Y, et al. 2022. Immunology. 167:576. PubMed
  428. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  429. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
  430. Naranjo S, et al. 2022. Genes Dev. 36:936. PubMed
  431. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
  432. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  433. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  434. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  435. Zhu H, et al. 2023. Clin Transl Radiat Oncol. 38:138. PubMed
  436. Schaefer-Babajew D, et al. 2023. Nature. 613:735. PubMed
  437. Edwards SC, et al. 2023. J Exp Med. 220: . PubMed
  438. Naylor G, et al. 2022. Cancers (Basel). 14: . PubMed
  439. Ronning KE, et al. 2022. J Neuroinflammation. 19:299. PubMed
  440. Pleuger C, et al. 2022. Elife. 11: . PubMed
  441. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  442. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  443. Hägglöf T, et al. 2023. Cell. 186:147. PubMed
  444. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  445. Gauthier L, et al. 2023. Nat Biotechnol. :. PubMed
  446. Ali LR, et al. 2023. J Exp Med. 220: . PubMed
  447. Zhou H, et al. 2023. Front Immunol. 13:1059687. PubMed
  448. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  449. Rosain J, et al. 2023. Cell. 186:621. PubMed
  450. Ernst MPT, et al. 2023. Hemasphere. 7:e824. PubMed
  451. Babl N, et al. 2023. Front Oncol. 13:1107484. PubMed
  452. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  453. Parida PK, et al. 2022. Cell Metab. 34:90. PubMed
  454. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  455. Salmon AJ, et al. 2022. Cancer Immunol Res. 10:597. PubMed
  456. Nelson LJ, et al. 2022. Cell Cycle. 21:1103. PubMed
  457. Kania AK, et al. 2022. J Immunol. 208:1873. PubMed
  458. Xu Y, et al. 2022. Bio Protoc. 12:e4354. PubMed
  459. McCafferty S, et al. 2022. Mol Ther. 30:2968. PubMed
  460. Pandey SP, et al. 2022. Cell Host Microbe. 30:1003. PubMed
  461. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  462. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  463. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  464. Park G, et al. 2023. Photochem Photobiol. 99:850. PubMed
  465. Zhao Y, et al. 2022. J Neurosci. . PubMed
  466. Lutz EA, et al. 2022. Proc Natl Acad Sci U S A. 119:e2205983119. PubMed
  467. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  468. Terminel MN, et al. 2022. BMC Neurosci. 23:58. PubMed
  469. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
  470. Prochazka L, et al. 2022. Mol Syst Biol. 18:e10886. PubMed
  471. Egli J, et al. 2022. MAbs. 14:2143009. PubMed
  472. Han X, et al. 2022. Nutrients. 14:. PubMed
  473. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  474. Schönberger K, et al. 2023. Anal Chem. 95:4325. PubMed
  475. Tschanz F, et al. 2021. Cancer Res Commun. 1:164. PubMed
  476. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  477. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  478. Muri J, et al. 2023. Nat Immunol. 24:604. PubMed
  479. Zhou P, et al. 2023. Immunity. 56:669. PubMed
  480. Ananya A, et al. 2023. Immun Ageing. 20:10. PubMed
  481. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  482. Luo X, et al. 2023. Methods Mol Biol. 2618:133. PubMed
  483. Jiang X, et al. 2023. J Clin Invest. 133:. PubMed
  484. Pankhurst TE, et al. 2023. Cell Rep. 42:112310. PubMed
  485. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  486. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  487. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  488. Xu Z, et al. 2023. Cancers (Basel). 15:. PubMed
  489. Liu L, et al. 2023. J Exp Clin Cancer Res. 42:85. PubMed
  490. Glasner A, et al. 2023. Nat Immunol. 24:1020. PubMed
  491. Sugita M, et al. 2023. Cell Death Dis. 14:305. PubMed
  492. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  493. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  494. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  495. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  496. Meckler JF, et al. 2023. Cancer Immunol Immunother. . PubMed
  497. Imai H, et al. 2023. iScience. 26:106822. PubMed
  498. Braun DJ, et al. 2023. PLoS One. 18:e0286495. PubMed
  499. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  500. Li JD, et al. 2023. Front Immunol. 14:1186393. PubMed
  501. Wu L, et al. 2023. Cell Res. . PubMed
  502. Cansever D, et al. 2023. Nat Immunol. . PubMed
  503. Liu X, et al. 2023. J Neuroinflammation. 20:144. PubMed
  504. Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed
  505. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  506. Liu Y, et al. 2022. Signal Transduct Target Ther. 7:347. PubMed
  507. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  508. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  509. Sagami S, et al. 2017. PLoS One. 10.1371/journal.pone.0169681. PubMed
  510. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  511. Montes de Oca M, et al. 2016. Cell Rep. 17:399-412. PubMed
  512. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  513. Gibb D, et al. 2016. EBioMedicine. 9: 77-86. PubMed
  514. Kallemeijn WW, et al. 2019. Cell Chem Biol. 26:892. PubMed
  515. Kollareddy M, et al. 2017. Cancer Lett. 10.1016/j.canlet.2017.05.027. PubMed
  516. Ajoge HO, et al. 2022. Viruses. 14:. PubMed
  517. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  518. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  519. He C, et al. 2022. Sci Adv. 8:eabm4552. PubMed
  520. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  521. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  522. Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
  523. Barros-Martins J, et al. 2021. Nat Med. 27:1525. PubMed
  524. Nordengrün M, et al. 2021. Front Immunol. 12:651060. PubMed
  525. Roberts A, et al. 2021. Sci Rep. 11:4030. PubMed
  526. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  527. Sheikh BN, et al. 2020. Nat Cell Biol. 22:828. PubMed
  528. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  529. Kilens S, et al. 2018. Nat Commun. 9:360. PubMed
  530. Merz SF, et al. 2019. Nat Commun. 10:2312. PubMed
  531. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  532. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  533. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  534. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  535. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  536. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  537. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  538. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  539. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  540. Sneller MC, et al. 2022. Nature. 606:375. PubMed
  541. Hamminger P, et al. 2021. J Autoimmun. 119:102610. PubMed
  542. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  543. Schalbetter SM, et al. 2022. Sci Adv. 8:eabi6672. PubMed
  544. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  545. Olingy C, et al. 2017. Sci Rep. 10.1038/s41598-017-00477-1. PubMed
  546. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  547. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  548. Liu HJ, et al. 2018. JCI Insight. 3. PubMed
  549. Zou L, et al. 2022. Brain Behav Immun. 100:10. PubMed
  550. Son ET, et al. 2021. J Clin Invest. 131:. PubMed
  551. Majstrowicz K, et al. 2021. J Cell Sci. 134:. PubMed
  552. Daniel S, et al. 2021. Infect Immun. 89:e0016521. PubMed
  553. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  554. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  555. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  556. Watters JM, et al. 2021. Biochem Biophys Res Commun. 534:773. PubMed
  557. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  558. Agudelo M, et al. 2021. J Exp Med. :218. PubMed
  559. Gaebler C, et al. 2021. Nature. 639:591. PubMed
  560. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  561. Verma M, et al. 2018. Cell Stem Cell. 23:530. PubMed
  562. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  563. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  564. Bouffi C, et al. 2015. J Immunol. 195: 2683-2695. PubMed
  565. Higuchi T, et al. 2015. Cancer Immunol Res. 3: 1257 - 1268. PubMed
  566. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  567. Xu AQ, et al. 2020. Elife. 9:00. PubMed
  568. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  569. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  570. Guarnaccia AD, et al. 2021. Cell Rep. 108636:34. PubMed
  571. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  572. Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
  573. Hemkemeyer SA, et al. 2020. J Biol Chem. 296:100136. PubMed
  574. Massafra V, et al. 2021. J Immunol. 207:493. PubMed
  575. Agudelo M, et al. 2022. J Exp Med. 219:. PubMed
  576. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  577. Woodruff MC, et al. 2022. Nature. :. PubMed
  578. Patricio DO, et al. 2022. Front Immunol. 13:1042463. PubMed
  579. Akiyama H, et al. 2020. J Virol. . PubMed
  580. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  581. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  582. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  583. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  584. Retamal‐Díaz A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01523. PubMed
  585. Wlodarska M et al. 2017. Cell host & microbe. 22(1):25-37 . PubMed
  586. Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
  587. Mahmoud W, et al. 2021. Cell Tissue Res. Online ahead of print. PubMed
  588. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  589. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  590. Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
  591. Koizumi SI, et al. 2018. Nat Commun. 9:5344. PubMed
  592. Chan JA, et al. 2020. Cell Rep Med. 1:100157. PubMed
  593. Michaud D, et al. 2020. Cytokine. 125:154817. PubMed
  594. Miller EB, et al. 2021. J Neuroinflammation. 18:235. PubMed
  595. Mills C, et al. 2022. Cells. 11:. PubMed
  596. Pettinato G, et al. 2021. Sci Adv. 7:. PubMed
  597. Godoy-Pacheco A, et al. 2022. Oncol Lett. 24:288. PubMed
  598. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  599. Sato R, et al. 2020. Int Immunol. 499:32. PubMed
  600. Aregger M, et al. 2020. Nat Metab. 0.429861111. PubMed
  601. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  602. PRADO-GARCIA H, et al. 2015. Anticancer Res. 35:1529. PubMed
  603. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  604. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  605. Casella G, et al. 2017. Sci Rep. . 10.1038/s41598-017-16702-w. PubMed
  606. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  607. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  608. Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed
  609. Mahadevan NR, et al. 2021. Cancer Discov. 11:1952. PubMed
  610. Alansary M, et al. 2021. Dent Traumatol. 37:90. PubMed
  611. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
  612. Song D, et al. 2021. Sci Rep. 11:22966. PubMed
  613. Aires V, et al. 2021. Front Immunol. 12:684430. PubMed
  614. Choi JE, et al. 2021. Nat Metab. 3:182. PubMed
  615. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  616. Wang K, et al. 2018. Medicine (Baltimore). 97:e0710. PubMed
  617. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  618. Grandclaudon M, et al. 2019. Cell. 179:432. PubMed
  619. Steinbach K, et al. 2016. J Exp Med. 213: 1571 - 1587. PubMed
  620. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  621. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  622. Wang Z, et al. 2021. bioRxiv. . PubMed
  623. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  624. Thyrsted J, et al. 2021. iScience. 24:103300. PubMed
  625. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  626. Viant C, et al. 2021. J Exp Med. 218:. PubMed
  627. Nakajima T, et al. 2021. J Exp Med. 218:. PubMed
  628. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  629. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  630. Li Y, et al. 2022. J Neuroinflammation. 19:261. PubMed
  631. Woodruff M, et al. 2020. medRxiv. . PubMed
  632. McHugh D, et al. 2020. Life Sci Alliance. 3:00. PubMed
  633. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  634. English KG, et al. 2022. Biomedicines. 10:. PubMed
  635. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  636. Stinson WA, et al. 2022. JCI Insight. 7:. PubMed
  637. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  638. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  639. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  640. Christopher GA, et al. 2021. Biomolecules. 12:. PubMed
  641. Cho A, et al. 2021. Nature. Online ahead of print. PubMed
  642. Clapes T, et al. 2021. Nat Cell Biol. 23:704. PubMed
  643. Espinoza J, et al. 2017. Oxidative Medicine and Cellular Longevity. 10.1155/2017/6781872. PubMed
  644. Pinder C, et al. 2017. J Immunol. 10.4049/jimmunol.1701253. PubMed
  645. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  646. Thompson EA, et al. 2021. Cell Rep. 108863:34. PubMed
  647. Popay TM, et al. 2021. Elife. 10: . PubMed
  648. Wan G, et al. 2021. Sci Rep. 11:22121. PubMed
  649. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  650. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  651. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  652. Xu Y, et al. 2021. Front Immunol. 12:666991. PubMed
  653. Zhang H, et al. 2021. Cell Rep. 36:109708. PubMed
  654. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  655. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  656. Scharer CD, et al. 2020. Nat Commun. 3989:11. PubMed
  657. Rodríguez-Rodríguez N, et al. 2015. J Immunol. 194:4207. PubMed
  658. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  659. Ito Y, et al. 2018. Cell. 174:636. PubMed
  660. Lim JME, et al. 2022. Cell Rep Med. 3:100793. PubMed
  661. Vanekova L, et al. 2022. Methods Protoc. 5:. PubMed
  662. Elias G, et al. 2022. Elife. 11:. PubMed
  663. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  664. van Vloten JP, et al. 2019. Mol Ther Methods Clin Dev. 13:154. PubMed
  665. Akuffo AA, et al. 2018. J Biol Chem. 293:6187. PubMed
  666. Morganti JM, et al. 2019. J Neuroinflammation. 16:98. PubMed
  667. McGinnis CS, et al. 2019. Nat Methods. 1.096527778. PubMed
  668. Günther T, et al. 2019. PLoS Pathog. 15:e1007838. PubMed
  669. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  670. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  671. Ruibal P, et al. 2016. Nature. 533: 100-104. PubMed
  672. Muthalagu N, et al. 2020. Cancer Discov. 1.022222222. PubMed
  673. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  674. Hemkemeyer SA, et al. 2020. J Biol Chem. . PubMed
  675. Luo G, et al. 2021. Sci Rep. 11:7841. PubMed
  676. Braun DA, et al. 2021. Cancer Cell. 39:632. PubMed
  677. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  678. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  679. Valestrand L, et al. 2022. Am J Pathol. . PubMed
  680. Espinal A, et al. 2022. Int J Mol Sci. 23:. PubMed
  681. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  682. Jalloh S, et al. 2022. PLoS Pathog. 18:e1010479. PubMed
  683. Salazar Y, et al. 2020. J Clin Invest. 130:3560. PubMed
  684. Bhattacharya P, et al. 2020. Elife. 9:00. PubMed
  685. Grubiši? V, et al. 2020. Cell Rep. 32:108100. PubMed
  686. Shim K, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.023. PubMed
  687. Tomić A, et al. 2016. PLoS Pathog. 12:e1006015. PubMed
  688. Filiano A, et al. 2016. Nature. 535:425-429. PubMed
  689. Armbruster N, et al. 2016. J Immunol. 196: 1284 - 1292. PubMed
  690. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  691. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  692. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  693. Waight JD, et al. 2018. Cancer Cell. 33:1033. PubMed
  694. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  695. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  696. Lozano-Ojalvo D, et al. 2021. Cell Rep. 36:109570. PubMed
  697. Dieterle ME, et al. 2021. Elife. 10:. PubMed
  698. Sharma V, et al. 2021. ACR Open Rheumatol. 3:277. PubMed
  699. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  700. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  701. Manouchehri N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  702. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  703. Noort RJ, et al. 2021. Front Cell Dev Biol. 9:659397. PubMed
  704. Soley BDS, et al. 2020. Br J Pharmacol. 177:3535. PubMed
  705. Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
  706. Zhang Y, et al. 2018. Front Microbiol. 9:2967. PubMed
  707. Grajchen E, et al. 2020. J Neuroinflammation. 0.863888889. PubMed
  708. Cloarec R, et al. 2016. PLoS One. 11: 0160176. PubMed
  709. Rouleau N, et al. 2020. Immunohorizons. 0.695833333. PubMed
  710. Rizvi F, et al. 2021. Nat Commun. 0.925694444. PubMed
  711. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  712. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  713. Wang Z, et al. 2021. Nature. 592:616. PubMed
  714. Ramos MIP, et al. 2021. Elife. 10:. PubMed
  715. Su Y, et al. 2021. Clin Cancer Res. :clincanres.2241.2021. PubMed
  716. Dudek M, et al. 2021. Nature. 592:444. PubMed
  717. Jacobsen H, et al. 2021. Nat Commun. 12:4957. PubMed
  718. Cillo AR, et al. 2021. Cell Rep Med. 2:100476. PubMed
  719. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
  720. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
  721. He Y, et al. 2022. Cells. 11:. PubMed
  722. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  723. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  724. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  725. McMaster S, et al. 2015. PLoS One. 10:115725. PubMed
  726. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  727. Manuszak C, et al. 2020. J Biol Methods. 7:e131. PubMed
  728. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  729. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  730. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  731. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  732. Wang Z, et al. 2021. Nature. 595:426. PubMed
  733. Mumby MJ, et al. 2021. J Virol. 95:e0058821. PubMed
  734. Chou TW, et al. 2021. Cell Death Dis. 12:756. PubMed
  735. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  736. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  737. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  738. Lien TS, et al. 2021. Front Immunol. 12:618577. PubMed
  739. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  740. Daniels M, et al. 2017. Sci Rep.. 10.1038/s41598-017-17387-x. PubMed
  741. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  742. Flies D, et al. 2015. J Immunol. 194:5294. PubMed
  743. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  744. Korin B, et al. 2020. Sleep. :43. PubMed
  745. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  746. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  747. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  748. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  749. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  750. Zhang Y, et al. 2022. Mater Today Bio. 15:100317. PubMed
  751. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  752. Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
  753. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  754. Lee HY, et al. 2021. Curr Protoc. 1:e272. PubMed
  755. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  756. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  757. Gaebler C, et al. 2020. bioRxiv. . PubMed
  758. Shimada BK, et al. 2020. Immunohorizons. 0.55625. PubMed
  759. Jeffery H, et al. 2017. Clin Exp Immunol. 10.1111/cei.12940. PubMed
  760. Hosking M, Flynn C, Whitton J 2016. PLoS Pathog. 12: 1005861. PubMed
  761. Bryan AF, et al. 2020. Nucleic Acids Res. 48:2924. PubMed
  762. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  763. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  764. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  765. Chakraborty A, et al. 2022. Methods Mol Biol. 2442:565. PubMed
  766. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  767. Kiesel VA, et al. 2022. Front Oncol. 12:767479. PubMed
  768. Gutierrez-Prat N, et al. 2022. Life Sci Alliance. 5:. PubMed
  769. Viant C, et al. 2020. Cell. 183:1298. PubMed
  770. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  771. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  772. Wachowska M, et al. 2020. Cancer Immunol Immunother. 69:1101. PubMed
  773. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  774. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  775. Sibler E, et al. 2021. Cells. 10:. PubMed
  776. Qin J, et al. 2020. Cancer Immunol Res. 8:1426. PubMed
  777. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  778. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  779. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  780. Sibler E, et al. 2022. Cancers (Basel). 14:. PubMed
  781. Spath S, et al. 2022. iScience. 25:104998. PubMed
  782. Farrand K, et al. 2022. Curr Protoc. 2:e482. PubMed
  783. Clutton G, et al. 2016. Sci Rep. 6:30749. PubMed
  784. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  785. Muchowicz A, et al. 2017. Eur J Cancer. 10.1016/j.ejca.2017.06.004. PubMed
  786. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  787. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  788. Zhang N, et al. 2022. Front Immunol. 13:926368. PubMed
  789. Cho A, et al. 2022. J Exp Med. 219:. PubMed
  790. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  791. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  792. Zhou P, et al. 2022. Sci Transl Med. :eabi9215. PubMed
  793. Sauler M, et al. 2022. Nat Commun. 13:494. PubMed
  794. Guarnaccia AD, et al. 2021. STAR Protoc. 2:101000. PubMed
  795. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  796. Gamradt S, et al. 2021. iScience. 24:103312. PubMed
  797. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  798. Goddery EN, et al. 2021. Front Immunol. 12:726421. PubMed
  799. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  800. Dar HH, et al. 2021. Redox Biol. 45:102045. PubMed

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
NA

Related FAQs

I am concerned about the spillover I am observing from the Zombie dye into its neighboring channels.
Rule of thumb with Zombie dyes is to titrate them down as much as possible to fit your application. This should potentially help with spillover. Secondly, Zombie positive events represent dead cells and are typically gated out from analysis.
How does the performance of your Zombie dye compare with competitors?

Zombie dyes have been tested against other leading competitors' fixable viability kits and given comparable results. We also highly recommend that you titrate down the amount of each dye used in order to best match the negative signals of your unstained sample and MFI- (mean fluorescence intensity) stained samples.

Can I use methanol/ethanol for fixation after using a Zombie dye?

Yes, most fixation reagents are fine to be used with Zombie dyes. However, it should be noted that Zombie dyes can still be sensitive to reactive oxygen species. Light exposure or reagents with hydrogen peroxide can lead to free radical formation, affecting fluorescence.

Can Zombie be used to determine bacteria, yeast viability?
We have not tested in house bacterial or yeast viability using Zombie dyes. It is not clear whether the difference between surface and intracellular signals will be significantly different in case of non mammalian cells.
Can I use Zombie with cells suspension containing serum?
Serum is full of proteins which will sequester the dye and thereby reducing its effective concentration. The basic rule of thumb with zombie is to titrate it based on your specific condition. Titration also helps reduce the background and spillover into other channels.
Can I use Zombie dyes for microscopy?

Zombie dyes tested in-house for microscopy applications will display data on the product technical datasheet. It should be noted that Zombie dyes may not work for dead cell discrimination in every microscopy application. Important considerations that may impact analysis are determining the signal level that constitutes a dead cell and identifying the proper plane to observe the dead cells.

Why can't I fix my cells prior to using Zombie dyes?

The fixation process can contort and alter the membrane of cells, effectively rendering them dead. Since the ability of the Zombie dyes to stain dead cells is correlated with cell permeability, your results may no longer be a valid representation of dead versus live cells.

Can I use Zombie dyes to detect apoptotic cells?

Yes, Zombie dyes can be used with apoptosis markers, such as Annexin V or Apotracker™ (shown below), to discriminate live, apoptotic, and dead cells.

One day-old C57BL/6 mouse thymocytes were stained with Apotracker™ Tetra Alexa Fluor® 647 and Zombie™ YG581. Zombie-dim/Apotracker™-positive cells are apoptotic, while double-positive cells are dead. Live cells are negative for both markers.

How should I store Zombie dyes?

Store the Zombie dye kit at -20°C upon receipt. Do not open vials until needed. Once DMSO is added, use immediately or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month.

Go To Top Version: 7    Revision Date: 12/18/2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account